A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
In this study, the bioequivalence of Epanutin Infatabs® 50 mg (sourced from Germany) and
Dilantin Infatabs® 50 mg (sourced from Australia) will be assessed. This is intended to be a
pivotal bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.